Tuberculosis (First Line Drugs for Treatment [Combinations]) (RXNORM)

active
URL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.843
Version
20200515
PublisherCSTE StewardDate2020-05-15T01:00:21-04:00Description

All prescribable medication formulations represented using either a "generic" or "brand-specific" concept. This includes RxNorm codes whose Term Type is SCD (semantic clinical drug), SBD (semantic brand drug), GPCK (generic pack), or BPCK (brand pack). SCDG (semantic clinical drug group), SBDG (semantic brand drug group), SCDF (semantic clinical drug form), IN (ingredient) or SBDF (semantic brand drug form) are NOT included in this value set.

Purpose

(Clinical Focus: This set of values contains codes for prescribable drugs that are combinations of two or more first-line treatment drugs.),(Data Element Scope: Medications that were administered, ordered or prescribed.),(Inclusion Criteria: Rifamate [rifampin 300 mg; isoniazid 150 mg]; Rifater [rifampin 120 mg; isoniazid 50 mg; pyrazinamide 300 mg]; IsonaRIF [rifampin 300 mg; isoniazid 150 mg]),(Exclusion Criteria: none)

Expansion
<<>>>
CodeDisplaySystem
198203http://www.nlm.nih.gov/research/umls/rxnorm
631357http://www.nlm.nih.gov/research/umls/rxnorm
206698http://www.nlm.nih.gov/research/umls/rxnorm
198384http://www.nlm.nih.gov/research/umls/rxnorm
206702http://www.nlm.nih.gov/research/umls/rxnorm
199756http://www.nlm.nih.gov/research/umls/rxnorm
199755http://www.nlm.nih.gov/research/umls/rxnorm